Hence, it was hypothesized that aging results in a steady decline in Nrf2 bioavailability accompanied by increased oxidative distress and mitochondrial dysfunction, which is a consequence of sarcopenia and one of its driving mechanisms. Here, NFE2L2 is linked to sarcopenia.